Probucol for Symptomatic Intracranial and Extracranial Artery Stenosis
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 5452 participants.
Also called NCT06225752
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 5,452 participants
- Registry
-
NCT06225752
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT06225752. Randomized; quadruple masking; primary purpose treatment. Start 2024-06-15 (actual); primary completion 2028-04-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Probucol for Symptomatic Intracranial and Extracranial Artery Stenosis
- Condition
- Ischemic Stroke
- Condition
- TIA (transient ischemic attack)
- Intervention (Drug)
- Probucol
- Intervention (Drug)
- Placebo probucol
- Lead sponsor
- First Affiliated Hospital of Wannan Medical College
- Collaborator
- Beijing Tiantan Hospital
Record details
- Record id
cardio:ct-nct06225752- Content hash
458851f2b4ad4c3ae3070d75316d3f9c7c6811fc8dc18348a9badc2619a8ca77